Phibro Animal Health Corporation (PAHC) Position Raised by Parametric Portfolio Associates LLC

Parametric Portfolio Associates LLC boosted its position in Phibro Animal Health Corporation (NASDAQ:PAHC) by 78.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,614 shares of the company’s stock after purchasing an additional 16,102 shares during the period. Parametric Portfolio Associates LLC owned about 0.09% of Phibro Animal Health Corporation worth $1,357,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in the stock. Alps Advisors Inc. lifted its position in Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after purchasing an additional 46 shares during the period. Louisiana State Employees Retirement System increased its holdings in Phibro Animal Health Corporation by 1.3% in the second quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock valued at $282,000 after buying an additional 100 shares in the last quarter. Arizona State Retirement System increased its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after buying an additional 100 shares in the last quarter. Nationwide Fund Advisors increased its holdings in Phibro Animal Health Corporation by 1.0% in the second quarter. Nationwide Fund Advisors now owns 10,866 shares of the company’s stock valued at $403,000 after buying an additional 110 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan increased its holdings in Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares in the last quarter. Hedge funds and other institutional investors own 50.36% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This piece was published by Week Herald and is the sole property of of Week Herald. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://weekherald.com/2017/11/15/phibro-animal-health-corporation-pahc-position-raised-by-parametric-portfolio-associates-llc.html.

Phibro Animal Health Corporation (NASDAQ PAHC) opened at $34.30 on Wednesday. The company has a debt-to-equity ratio of 1.91, a quick ratio of 1.85 and a current ratio of 3.26. Phibro Animal Health Corporation has a 12 month low of $26.10 and a 12 month high of $40.25. The firm has a market cap of $1,384.30, a P/E ratio of 22.52, a PEG ratio of 4.04 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last released its earnings results on Monday, November 6th. The company reported $0.38 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.37 by $0.01. The firm had revenue of $193.40 million during the quarter, compared to analysts’ expectations of $189.89 million. Phibro Animal Health Corporation had a net margin of 8.87% and a return on equity of 42.75%. Phibro Animal Health Corporation’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period in the previous year, the company earned $0.36 EPS. research analysts predict that Phibro Animal Health Corporation will post 1.57 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Shareholders of record on Wednesday, December 6th will be paid a $0.10 dividend. The ex-dividend date is Tuesday, December 5th. This represents a $0.40 annualized dividend and a yield of 1.17%. Phibro Animal Health Corporation’s payout ratio is currently 23.53%.

A number of research analysts have issued reports on the stock. Piper Jaffray Companies set a $41.00 target price on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a report on Friday, October 6th. Zacks Investment Research cut shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. BidaskClub cut shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 23rd. Credit Suisse Group raised their price objective on shares of Phibro Animal Health Corporation from $36.00 to $37.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Finally, ValuEngine cut shares of Phibro Animal Health Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, November 9th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $38.25.

In other Phibro Animal Health Corporation news, insider Dean J. Warras sold 10,000 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $35.70, for a total value of $357,000.00. Following the completion of the sale, the insider now directly owns 10,000 shares of the company’s stock, valued at approximately $357,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Larry Lee Miller sold 32,459 shares of Phibro Animal Health Corporation stock in a transaction that occurred on Thursday, September 7th. The stock was sold at an average price of $35.59, for a total transaction of $1,155,215.81. Following the completion of the sale, the chief operating officer now directly owns 4,237 shares of the company’s stock, valued at $150,794.83. The disclosure for this sale can be found here. Insiders sold a total of 284,767 shares of company stock valued at $10,317,421 over the last ninety days. 51.88% of the stock is owned by corporate insiders.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Institutional Ownership by Quarter for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply